Remove Media Remove Safety Remove Topical
article thumbnail

FDA Issues Warning Letters to CBD Manufacturers Making “Over-The-Line” Health Claims

Canna Law Blog

The letters were sent “in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.” For a complete list of questions and topics identified by the FDA, see here.

CBD 103
article thumbnail

New- ANH-Intl Special Report: Is safety the new gremlin for CBD regulation?

Cannabis Law Report

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

US Hemp Roundtable Analysis Of FDA CBD Report To Congress

Cannabis Law Report

hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.

Hemp 71
article thumbnail

Press Release: NEWAGE LAUNCHES ‘NHANCED HEMP TOPICALS IN AUSTRALIA AND NEW ZEALAND

Cannabis Law Report

KEY HIGHLIGHTS: NewAge launches its ‘NHANCED Hemp Topical Products in Australia and New Zealand. For investor inquiries about NewAge Beverages Corporation please contact: Media: Desiree Rosa, MULTIPLY. NHANCED Hemp Topical Products. DENVER, COLORADO, Dec. ” About NewAge Beverages Corporation (NASDAQ: NBEV ).

Topical 45
article thumbnail

Virpax® Successfully Completes Preclinical Dermal Safety Studies for Epoladerm™

Cannabis Law Report

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders, and anti-viral indications, reported positive results of four preclinical dermal safety studies for Epoladerm™ (diclofenac epolamine). Media: Laura Radocaj. Chief Financial Officer.

Safety 40
article thumbnail

Travelers Institute Announces Fall 2021 Virtual Programming

Cannabis Law Report

Our upcoming lineup covers a wide range of topics that are relevant to both individuals and businesses – from politics and new legislation to public health issues, cybersecurity and technology advancements,” said Woodward. Media: Sperry Mylott, 860.277.5075. 22 – “High Risk? About the Travelers Institute. smylott@travelers.com.

article thumbnail

FDA Press Release: FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns

Cannabis Law Report

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 49